CA2068660A1 - Non-invasive method for isolation and detection of fetal dna - Google Patents
Non-invasive method for isolation and detection of fetal dnaInfo
- Publication number
- CA2068660A1 CA2068660A1 CA002068660A CA2068660A CA2068660A1 CA 2068660 A1 CA2068660 A1 CA 2068660A1 CA 002068660 A CA002068660 A CA 002068660A CA 2068660 A CA2068660 A CA 2068660A CA 2068660 A1 CA2068660 A1 CA 2068660A1
- Authority
- CA
- Canada
- Prior art keywords
- fetal
- detection
- fetal dna
- isolation
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5002—Partitioning blood components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
Abstract
A method of isolating fetal nucleated cells, particularly fetal nucleated erythrocytes, from a maternal blood sample, by means of an antigen present on the cell surface of the fetal erythrocytes. A method of detecting fetal DNA of interest, which is a gene or gene portion associated with a disease or condition, a chromosomal abnormality or sex-specific DNA, in a maternal blood sample. The presence or absence, as well as the quantity of fetal DNA of interest in a maternal sample can be determined. The claimed method of detection can be used prenatally or postnatally and is particularly useful because it is noninvasive and can be carried out early in pregnancy.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US436,057 | 1982-10-22 | ||
US43605789A | 1989-11-13 | 1989-11-13 | |
PCT/US1990/006623 WO1991007660A1 (en) | 1989-11-13 | 1990-11-13 | Non-invasive method for isolation and detection of fetal dna |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2068660A1 true CA2068660A1 (en) | 1991-05-14 |
CA2068660C CA2068660C (en) | 2007-05-01 |
Family
ID=38051303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002068660A Expired - Lifetime CA2068660C (en) | 1989-11-13 | 1990-11-13 | Non-invasive method for isolation and detection of fetal dna |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2068660C (en) |
-
1990
- 1990-11-13 CA CA002068660A patent/CA2068660C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2068660C (en) | 2007-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2487095A (en) | Non-invasive method for isolation and detection of foetal DNA | |
ES2010248A6 (en) | System for isolating and identifying leukocytes. | |
CA2140278A1 (en) | Enriching and identyfing fetal cells in maternal blood for in situ hybridization | |
EP0447424A4 (en) | Isolation of fetal cells from maternal blood to enable prenatal diagnosis | |
AU4920097A (en) | Use of anti-embryonic hemoglobin antibodies to identify fetal cells | |
CA2122473A1 (en) | Nuclear Matrix Protein Fluid Assay | |
Zhong et al. | Prenatal identification of fetal genetic traits | |
EP0353985A3 (en) | Nucleic acid probe for detection of neisseria gonorrhoea | |
PT923730E (en) | Prenatal screening for down`s syndrome using hyperglycosylated gonadotropin | |
NO932320L (en) | PROCEDURE FOR DETERMINING AN ANALYST IN A SAMPLE AND EQUIPMENT FOR THIS | |
MXPA96004278A (en) | Differential expansion of fetal stem cells in the maternal circulation for use in prenatal genetic analysis. | |
GB2326943B (en) | Detection of fetal red cells in maternal blood | |
CA2068660A1 (en) | Non-invasive method for isolation and detection of fetal dna | |
AU6817487A (en) | Pregnancy test with epf | |
Ward | 1 Techniques of chorion villus sampling | |
Fernandes et al. | An objective filter-based, enzymatic method for the in vivo measurement of the migration of human polymorphonuclear leucocytes | |
Archer et al. | Prenatal diagnosis of Hunter syndrome | |
Burstein et al. | High long-standing fertilizing capacity of human sperm isolated for male sex preselection | |
Kulkarni et al. | Prenatal diagnosis of 45, X/46, XX mosaicism in the fetus. Should the pregnancy be terminated? | |
Minelli et al. | Prenatal diagnosis of metabolic diseases on chorionic villi obtained before the ninth week of pregnancy | |
WO2002021132A3 (en) | Cell assays | |
Lane, AB, Skikne, MI & Jenkins | The prenatal diagnosis of Tay-Sachs disease | |
Potier et al. | Amniotic Fluid α-Galactosidase Activity: an Indicator of Gestational Age | |
Olson et al. | Chorionic villus sampling: First-trimester prenatal diagnosis of partial 10q trisomy in a family with a 410 translocation | |
Sinosich et al. | Pregnancy‐Associated Plasma Protein‐A |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |